{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:18:31Z","timestamp":1790410711448,"version":"4.1.0"},"reference-count":77,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T00:00:00Z","timestamp":1420156800000},"content-version":"unspecified","delay-in-days":488,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>This report updates US Public Health Service recommendations for the management of healthcare personnel (HCP) who experience occupational exposure to blood and\/or other body fluids that might contain human immunodeficiency virus (HIV). Although the principles of exposure management remain unchanged, recommended HIV postexposure prophylaxis (PEP) regimens and the duration of HIV follow-up testing for exposed personnel have been updated. This report emphasizes the importance of primary prevention strategies, the prompt reporting and management of occupational exposures, adherence to recommended HIV PEP regimens when indicated for an exposure, expert consultation in management of exposures, follow-up of exposed HCP to improve adherence to PEP, and careful monitoring for adverse events related to treatment, as well as for virologie, immunologic, and serologic signs of infection. To ensure timely postexposure management and administration of HIV PEP, clinicians should consider occupational exposures as urgent medical concerns, and institutions should take steps to ensure that staff are aware of both the importance of and the institutional mechanisms available for reporting and seeking care for such exposures. The following is a summary of recommendations: (1) PEP is recommended when occupational exposures to HIV occur; (2) the HIV status of the exposure source patient should be determined, if possible, to guide need for HIV PEP; (3) PEP medication regimens should be started as soon as possible after occupational exposure to HIV, and they should be continued for a 4-week duration; (4) new recommendation\u2014PEP medication regimens should contain 3 (or more) antiretroviral drugs (listed in Appendix A) for all occupational exposures to HIV; (5) expert consultation is recommended for any occupational exposures to HIV and at a minimum for situations described in Box 1; (6) close follow-up for exposed personnel (Box 2) should be provided that includes counseling, baseline and follow-up HIV testing, and monitoring for drug toxicity; follow-up appointments should begin within 72 hours of an HIV exposure; and (7) new recommendation\u2014if a newer fourth-generation combination HIV p24 antigen-HIV antibody test is utilized for follow-up HIV testing of exposed HCP, HIV testing may be concluded 4 months after exposure (Box 2); if a newer testing platform is not available, follow-up HIV testing is typically concluded 6 months after an HIV exposure.<\/jats:p>","DOI":"10.1086\/672271","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T21:52:44Z","timestamp":1375739564000},"page":"875-892","source":"Crossref","is-referenced-by-count":286,"title":["Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis"],"prefix":"10.1017","volume":"34","author":[{"given":"David T.","family":"Kuhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Struble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Heneine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasavi","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura W.","family":"Cheever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelisa L.","family":"Panlilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"US Public Health Service Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,1,2]]},"reference":[{"key":"S0195941700033671_ref004","first-page":"1","article-title":"Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"S0195941700033671_ref012","volume-title":"The National Surveillance System for Healthcare Workers (NaSH): Summary Report for Blood and Body Fluid Exposure Data Collected from Participating Healthcare Facilities (June 1995 through December 2007)","year":"2011"},{"key":"S0195941700033671_ref040","volume-title":"Presented at: 10th Conference on Retroviruses and Opportunistic Infections","author":"Puro","year":"2003"},{"key":"S0195941700033671_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2007.10.007"},{"key":"S0195941700033671_ref074","first-page":"321","article-title":"Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids","volume":"132","author":"Meienberg","year":"2002","journal-title":"Swiss Med Wkly"},{"key":"S0195941700033671_ref059","volume-title":"Presented at: 13th Annual Meeting of the Society for Healthcare Epidemiology of America","author":"Panlilio","year":"2003"},{"key":"S0195941700033671_ref036","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124080-00003"},{"key":"S0195941700033671_ref042","first-page":"156","article-title":"2011 Update of the drug resistance mutations in HIV-1","volume":"19","author":"Johnson","year":"2011","journal-title":"Top Antivir Med"},{"key":"S0195941700033671_ref063","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1128\/JVI.74.20.9771-9775.2000","article-title":"Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2)","volume":"74","author":"Often","year":"2000","journal-title":"J Virol"},{"key":"S0195941700033671_ref031","first-page":"3753","volume-title":"Principles and Practice of Infectious Diseases","author":"Henderson","year":"2009"},{"key":"S0195941700033671_ref030","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus SIVmine infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"S0195941700033671_ref067","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283388742"},{"key":"S0195941700033671_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)74610-9"},{"key":"S0195941700033671_ref060","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.09.011"},{"key":"S0195941700033671_ref046","doi-asserted-by":"publisher","DOI":"10.1086\/605124"},{"key":"S0195941700033671_ref029","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.3.625"},{"key":"S0195941700033671_ref002","first-page":"1","article-title":"Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use","volume":"39","year":"1990","journal-title":"MMWR Recomm Rep"},{"key":"S0195941700033671_ref032","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/501736","article-title":"Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry","volume":"21","author":"Wang","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"S0195941700033671_ref025","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199906180-00007"},{"key":"S0195941700033671_ref024","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905273402102"},{"key":"S0195941700033671_ref052","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000242814.42344.77"},{"key":"S0195941700033671_ref041","doi-asserted-by":"publisher","DOI":"10.1086\/502120"},{"key":"S0195941700033671_ref023","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1589"},{"key":"S0195941700033671_ref008","first-page":"1","article-title":"US Department of Health and Human Services. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"S0195941700033671_ref028","volume-title":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents","year":"2012"},{"key":"S0195941700033671_ref006","first-page":"1","article-title":"US Public Health Service. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis","volume":"54","author":"Panlilio","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"S0195941700033671_ref057","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31820bd2b6"},{"key":"S0195941700033671_ref005","first-page":"1","article-title":"Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"S0195941700033671_ref038","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-200203000-00014"},{"key":"S0195941700033671_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89441-7"},{"key":"S0195941700033671_ref022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711203372101"},{"key":"S0195941700033671_ref003","first-page":"468","article-title":"Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV","volume":"45","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S0195941700033671_ref037","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-200011000-00011"},{"key":"S0195941700033671_ref061","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181fbca44"},{"key":"S0195941700033671_ref014","volume-title":"Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting Summary Report, June 14-15, 2012, Atlanta, GA.","year":"2012"},{"key":"S0195941700033671_ref044","doi-asserted-by":"publisher","DOI":"10.1086\/502065"},{"key":"S0195941700033671_ref015","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90209-6"},{"key":"S0195941700033671_ref043","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(01)90811-4"},{"key":"S0195941700033671_ref045","volume-title":"Presented at: 6th Conference on Retroviruses and Opportunistic Infections","author":"Perdue","year":"1999"},{"key":"S0195941700033671_ref009","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.6.1475"},{"key":"S0195941700033671_ref016","first-page":"522","article-title":"Transmission of HIV by human bite","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"S0195941700033671_ref077","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00076-4"},{"key":"S0195941700033671_ref027","doi-asserted-by":"publisher","DOI":"10.1086\/650005"},{"key":"S0195941700033671_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90838-7"},{"key":"S0195941700033671_ref049","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301240-00023"},{"key":"S0195941700033671_ref066","doi-asserted-by":"publisher","DOI":"10.1086\/314948"},{"key":"S0195941700033671_ref053","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730030-00004"},{"key":"S0195941700033671_ref055","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00514-10"},{"key":"S0195941700033671_ref056","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907736"},{"key":"S0195941700033671_ref021","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410120035005"},{"key":"S0195941700033671_ref064","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5239.1197"},{"key":"S0195941700033671_ref065","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371102"},{"key":"S0195941700033671_ref073","doi-asserted-by":"publisher","DOI":"10.1300\/J010v21n03_06"},{"key":"S0195941700033671_ref071","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.21.2722"},{"key":"S0195941700033671_ref070","doi-asserted-by":"publisher","DOI":"10.1086\/520242"},{"key":"S0195941700033671_ref017","first-page":"402","article-title":"The potential for transmission of human immunodeficiency virus through human bites","volume":"6","author":"Richman","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"S0195941700033671_ref075","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.09.023"},{"key":"S0195941700033671_ref076","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703273361304"},{"key":"S0195941700033671_ref050","volume-title":"Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2011","year":"2011"},{"key":"S0195941700033671_ref013","volume-title":"Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting Summary Report, November 3-4, 2011, Washington, DC.","year":"2011"},{"key":"S0195941700033671_ref039","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2000.0765"},{"key":"S0195941700033671_ref026","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350801300513","article-title":"Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?","volume":"13","author":"St\u00fcrmer","year":"2008","journal-title":"Antivir Ther"},{"key":"S0195941700033671_ref058","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6580"},{"key":"S0195941700033671_ref020","doi-asserted-by":"publisher","DOI":"10.1089\/088922204323048087"},{"key":"S0195941700033671_ref072","first-page":"1153","article-title":"Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures\u2014worldwide, 1997-2000","volume":"49","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S0195941700033671_ref048","doi-asserted-by":"publisher","DOI":"10.1136\/sti.78.1.58"},{"key":"S0195941700033671_ref007","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"S0195941700033671_ref047","doi-asserted-by":"publisher","DOI":"10.1086\/651233"},{"key":"S0195941700033671_ref051","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834cdb71"},{"key":"S0195941700033671_ref034","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05005-9"},{"key":"S0195941700033671_ref010","volume-title":"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States","year":"2012"},{"key":"S0195941700033671_ref069","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328351f68f"},{"key":"S0195941700033671_ref033","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-199812000-00010"},{"key":"S0195941700033671_ref019","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-8-16"},{"key":"S0195941700033671_ref062","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.09.010"},{"key":"S0195941700033671_ref068","volume-title":"Presented at: CROI 2010: 17th Conference on Retroviruses and Opportunistic Infections","author":"Kim","year":"2010"},{"key":"S0195941700033671_ref054","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01117-08"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0195941700033671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T02:09:55Z","timestamp":1715825395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0195941700033671\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0195941700033671"],"URL":"https:\/\/doi.org\/10.1086\/672271","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}